Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells

被引:18
作者
Guo, Xiaoyu [1 ]
Luo, Ziguo [1 ]
Xia, Tong [1 ]
Wu, Lanxiang [1 ]
Shi, Yanshu [2 ]
Li, Ying [1 ]
机构
[1] Chongqing Med Univ, Life Sci Inst, 1 Xueyuan Rd, Chongqing 400016, Peoples R China
[2] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
BMP2; Cancer stem cell; CeRNA; Gliobalstoma; RNA-seq; TMZ; EXPRESSION; PROTEIN; MICRORNAS; PROLIFERATION; PATHOGENESIS; RECEPTOR; THERAPY; TARGET; GENES; EGFR;
D O I
10.1016/j.gendis.2019.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glioblastoma multiform (GBM) is the most lethal intracranial tumor in adults. Glioblastoma stem-like cells (GSCs) are responsible for tumorigenesis and chemotherapy resistance. BMPs are known to increase temozolomide (TMZ) response in GSCs, however, the intracellular molecular mechanism remains largely unknown. In this study, we built a GSC cell model called U87S, and performed RNA sequencing to identify differentially expressed (DE) miRNA profiles in U875 cells treated with BMP2, TMZ or combined BMP2 and TMZ respectively. Bioinformatics analysis revealed that most DE miRNAs were involved in the cancer pathways, suggesting their crucial roles in gliomagenesis. Eight miRNAs from RNA-seq were validated. Four out of these miRNAs (has-miR-199a-3p, hsa-miR-374b-5p, hsa-miR-320d, and hsa-miR-339-5p) were found significantly up-regulated in GBM tumor tissues. One of them, hsa-miR-199a-3p, was significantly correlated with the survival of GBM patients, and differentially expressed in U875 cells. Expression of hsa-miR-199a-3p was up-regulated by BMP. Overexpression of hsa-miR-199a-3p in U875 cells inhibited cell viability and enhanced the cytotoxicity of TMZ. And activation of BMP boosted the effect of hsa-miR-199a-3p on cell viability and TMZ-mediated cytotoxicity. Besides, expressions of five predicted targets of hsa-miR-199a-3p were evaluated. Four of them were differentially expressed in GBM tumors. And one of them, SLC22A18, was associated with the survival of GBM patients. In the end, a hsa-miR-199a-3p-mediated ceRNA network was constructed for the convenience of future study. Together, our data provided DE miRNA expression profiles associated with BMP2 and TMZ in GSCs, which might lead to finding out miRNA-based target therapies that specially target GSCs. Copyright (C) 2019, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:424 / 439
页数:16
相关论文
共 58 条
[1]   Predicting effective microRNA target sites in mammalian mRNAs [J].
Agarwal, Vikram ;
Bell, George W. ;
Nam, Jin-Wu ;
Bartel, David P. .
ELIFE, 2015, 4
[2]   MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review [J].
Ahir, Bhavesh K. ;
Ozer, Howard ;
Engelhard, Herbert H. ;
Lakka, Sajani S. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 120 :22-33
[3]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   Transforming growth factor β and bone morphogenetic protein actions in brain tumors [J].
Caja, Laia ;
Bellomo, Claudia ;
Moustakas, Aristidis .
FEBS LETTERS, 2015, 589 (14) :1588-1597
[6]   Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP [J].
Celiku, Orieta ;
Johnson, Seth ;
Zhao, Shuping ;
Camphausen, Kevin ;
Shankavaram, Uma .
PLOS ONE, 2014, 9 (07)
[7]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[8]   Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy [J].
Chu, Sheng-Hua ;
Ma, Yan-Bin ;
Feng, Dong-Fu ;
Li, Zhi-Qiang ;
Jiang, Pu-Cha .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[9]   Survival in glioblastoma: a review on the impact of treatment modalities [J].
Delgado-Lopez, P. D. ;
Corrales-Garcia, E. M. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (11) :1062-1071
[10]   MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM) [J].
Fan, Xuelong ;
Zhou, Shangcheng ;
Zheng, Miao ;
Deng, Xiyun ;
Yi, Yinsha ;
Huang, Tieniu .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 88 :507-514